{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:45:09Z","timestamp":1765806309599},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2000,1,25]],"date-time":"2000-01-25T00:00:00Z","timestamp":948758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,1,25]],"date-time":"2000-01-25T00:00:00Z","timestamp":948758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2000,2,1]]},"DOI":"10.1038\/sj.leu.2401673","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T18:28:56Z","timestamp":1031164136000},"page":"221-225","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Individualized methotrexate dosing in children with relapsed acute lymphoblastic leukemia"],"prefix":"10.1038","volume":"14","author":[{"given":"AM","family":"Wall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Gajjar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Link","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C-H","family":"Pui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MV","family":"Relling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2000,1,25]]},"reference":[{"key":"BF2401673_CR1","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1056\/NEJM199808273390907","volume":"339","author":"C-H Pui","year":"1998","unstructured":"Pui C-H, Evans WE . Acute lymphoblastic leukemia New Engl J Med 1998 339: 605\u2013615","journal-title":"New Engl J Med"},{"key":"BF2401673_CR2","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1056\/NEJM199506153322407","volume":"332","author":"C-H Pui","year":"1995","unstructured":"Pui C-H . Childhood leukemias New Engl J Med 1995 332: 1618\u20131630","journal-title":"New Engl J Med"},{"key":"BF2401673_CR3","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1182\/blood.V88.3.831.831","volume":"88","author":"GK Rivera","year":"1996","unstructured":"Rivera GK, Hudson MM, Liu Q, Benaim E, Ribeiro R, Crist WM, Pui C-H . Effectiveness of intensified rotational combination chemotherapy for late hematologic relapse of childhood acute lymphoblastic leukemia Blood 1996 88: 831\u2013837","journal-title":"Blood"},{"key":"BF2401673_CR4","first-page":"435","volume":"21","author":"WE Evans","year":"1998","unstructured":"Evans WE, Relling MV, Rodman JH, Crom WR, Boyett JM, Pui C-H . Conventional versus individualized chemotherapy for childhood acute lymphoblastic leukemia New Engl J Med 1998 21: 435\u2013437","journal-title":"New Engl J Med"},{"key":"BF2401673_CR5","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/0277-5379(90)90023-M","volume":"26","author":"G Milano","year":"1990","unstructured":"Milano G, Thyss A, Debeauvais FS, Laureys G, Benoit Y, Deville A, Dutour C, Robert A, Otten J . Behar C, Frappaz D. CSF drug levels for children with acute lymphoblastic leukemia treated by 5g\/m2 methotrexate Eur J Cancer 1990 26: 492\u2013495","journal-title":"Eur J Cancer"},{"key":"BF2401673_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0010-468X(79)90025-4","volume":"9","author":"DZ D'Argenio","year":"1979","unstructured":"D'Argenio DZ, Schumitzky A . A program package for simulation and parameter estimation in pharmacokinetics Comp Prog Biomed 1979 9: 115\u20131134","journal-title":"Comp Prog Biomed"},{"key":"BF2401673_CR7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1542\/peds.58.2.259","volume":"58","author":"GJ Schwartz","year":"1976","unstructured":"Schwartz GJ, Haycock GB, Edelmann CM, Spitzer A . A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine Pediatrics 1976 58: 259\u2013263","journal-title":"Pediatrics"},{"key":"BF2401673_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/028418698429586","volume":"37","author":"C Rask","year":"1998","unstructured":"Rask C, Albertioni F, Bentzen M, Schroeder H, Peterson C . Clinical and pharmacokinetic risk factors for high-dose methotrexate-induced toxicity in children with acute lymphoblastic leukemia Acta Oncol 1998 37: 277\u2013284","journal-title":"Acta Oncol"},{"key":"BF2401673_CR9","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1200\/JCO.1994.12.8.1667","volume":"12","author":"MV Relling","year":"1994","unstructured":"Relling MV, Fairclough D, Ayers D, Crom WR, Rodman JH, Pui C-H, Evans WE . Patient characteristics associated with high-risk methotrexate concentrations and toxicity J Clin Oncol 1994 12: 1667\u20131672","journal-title":"J Clin Oncol"},{"key":"BF2401673_CR10","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1182\/blood.V84.9.3122.3122","volume":"84","author":"A Reiter","year":"1994","unstructured":"Reiter A, Schrappe M, Ludwig W-D, Hiddemann W, Sauter S, Henze G, Zimmermann M, Lampart F, Havers W, Niethammer D, Odenwald E, Ritter J, Mann G, Welte K, Gadner H, Riehm H . Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86 Blood 1994 84: 3122\u20133133","journal-title":"Blood"},{"key":"BF2401673_CR11","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1200\/JCO.1999.17.3.818","volume":"17","author":"C-H Pui","year":"1999","unstructured":"Pui C-H, Boyett JM, Relling MV, Harrison PL, Rivera GK, Behn FG, Sandlund JT, Ribeiro RC, Rubnitz JE, Gajjar A, Evans WE . Sex differences in prognosis for children with acute lymphoblastic leukemia J Clin Oncol 1999 17: 818\u2013824","journal-title":"J Clin Oncol"},{"key":"BF2401673_CR12","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1182\/blood.V92.10.3569","volume":"92","author":"FM Balis","year":"1998","unstructured":"Balis FM, Holcenberg JS, Poplack DG, Ge J, Sather HN, Murphy RF, Ames MM, Waskerwitz MJ, Tubergen DG, Simm S, Gilchrist GS, Bleyer WA . Pharmacokinetics and pharmacodynamics or oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch study Blood 1998 92: 3569\u20133577","journal-title":"Blood"},{"key":"BF2401673_CR13","first-page":"741","volume":"i","author":"H Sather","year":"1981","unstructured":"Sather H, Miller D, Nesbit M, Heyn R, Hammond D . Differences in prognosis for boys and girls with acute lymphoblastic leukemia Lancet 1981 i: 741\u2013743","journal-title":"Lancet"},{"key":"BF2401673_CR14","first-page":"243","volume":"5","author":"G Gustafsson","year":"1983","unstructured":"Gustafsson G, Kreuger A . Sex and other prognostic factors in acute lymphoblastic leukemia in childhood Am J Pediat Hematol Oncol 1983 5: 243\u2013250","journal-title":"Am J Pediat Hematol Oncol"},{"key":"BF2401673_CR15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1651-2227.1992.tb12081.x","volume":"81","author":"M Lanning","year":"1992","unstructured":"Lanning M, Garwicz S, Hertz H, Jonmundsson G, Kreuger A, Lie SO, Moe PJ, Salmi TT, Schroder H, Siimes MA, Wesenberg F, Yssing M, Ahstrom L, Gustafsson G . Superior treatment results in females with high risk acute lymphoblastic leukemia in childhood Acta Paediat 1992 81: 66\u201368","journal-title":"Acta Paediat"},{"key":"BF2401673_CR16","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1200\/JCO.1998.16.8.2854","volume":"16","author":"JJ Shuster","year":"1998","unstructured":"Shuster JJ, Wacker P, Pullen J, Humbert J, Land VJ, Mahoney DH Jr, Lauer S, Look AT, Borowitz MJ, Carroll AJ, Camitta B . Prognostic significance of sex in childhood precursor acute lymphoblastic leukemia: a pediatric oncology group study J Clin Oncol 1998 16: 2854\u20132863","journal-title":"J Clin Oncol"},{"key":"BF2401673_CR17","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/1097-0142(19910201)67:3<550::AID-CNCR2820670303>3.0.CO;2-#","volume":"67","author":"RA Krance","year":"1991","unstructured":"Krance RA, Newman EM, Ravindranath Y, Harris MB, Brecher M, Wimmer R, Shuster JJ, Land VJ, Pullen J, Crist W, Pinkel D . A pilot study of intermediate-dose methotrexate and cytosine arabinoside, \u2018spread-out\u2019 or \u2018up-front\u2019, in continuation therapy for childhood non-T, non-B acute lymphoblastic leukemia: a Pediatric Oncology Group study Cancer 1991 67: 550\u2013556","journal-title":"Cancer"},{"key":"BF2401673_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3109\/08880018609031196","volume":"3","author":"C Patte","year":"1986","unstructured":"Patte C, Bernard A, Hartmann O, Kalifa C, Flamant F, Lemerle J . High-dose methotrexate and continuous infusion Ara-C in children's non-Hodgkin's lymphoma Pediat Hematol Oncol 1986 3: 11\u201318","journal-title":"Pediat Hematol Oncol"},{"key":"BF2401673_CR19","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1200\/JCO.1994.12.9.1939","volume":"12","author":"Land","year":"1994","unstructured":"Land, VJ, Shuster WM, Crist Y, Ravindranath MB, Harns MB, Krance RA, Pinkel D, Pullen DJ . Comparison of two schedules of intermediate-dose methotrexate and cytarabine consolidation therapy for childhood B-precursor cell acute lymphoblastic leukemia: a pediatric oncology group study J Clin Oncol 1994 12: 1939\u20131945","journal-title":"J Clin Oncol"},{"key":"BF2401673_CR20","first-page":"331","volume":"2","author":"ML Graham","year":"1996","unstructured":"Graham ML, Shuster JJ, Kamen BA, Land VJ, Borowitz MJ, Camitta B, Cheo DL, Harrison MP, Leventhal BG, Pinkel DP, Pullen DJ, Steuber P, Whitehead VM . Changes in the red blood cell methotrexate pharmacology and their impact on outcome when cytarabine is infused with methotrexate in the therapy of acute lymphocytic leukemia in children: a pediatric oncology group study Clin Cancer Res 1996 2: 331\u2013337","journal-title":"Clin Cancer Res"},{"key":"BF2401673_CR21","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1200\/JCO.1998.16.1.246","volume":"16","author":"DH Mahoney","year":"1998","unstructured":"Mahoney DH, Shuster J, Nitschke R, Lauer SJ, Winick N, Steuber CP, Camitta B . Intermediate-dose intravenous methotrexate with intravenous mercaptopurine is superior to repetitive low-dose oral methotrexate with intravenous mercaptopurine for children with lower-risk B-lineage acute lymphoblastic leukemia J Clin Oncol 1998 16: 246\u2013254","journal-title":"J Clin Oncol"},{"key":"BF2401673_CR22","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1200\/JCO.1994.12.7.1383","volume":"12","author":"B Camitta","year":"1994","unstructured":"Camitta B, Mahoney D, Leventhat B, Lauer SJ, Shuster JJ, Adair S, Civin C, Munoz L, Steuber P, Strother D, Kamen BA . Intensive intravenous methotrexate and mercaptopurine treatment of higher-risk non-T, non-B acute lymphocytic leukemia: a pediatric oncology group study J Clin Oncol 1994 12: 1383\u20131389","journal-title":"J Clin Oncol"},{"key":"BF2401673_CR23","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1200\/JCO.1989.7.10.1539","volume":"7","author":"B Camitta","year":"1989","unstructured":"Camitta B, Leventhal B, Lauer S, Shuster JJ, Adair S, Casper J, Civin C, Graham M, Mahoney D, Munoz L . Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a pediatric oncology group study J Clin Oncol 1989 7: 1539\u20131544","journal-title":"J Clin Oncol"},{"key":"BF2401673_CR24","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1056\/NEJM198602203140803","volume":"314","author":"WE Evans","year":"1986","unstructured":"Evans WE, Crom WR, Abromowitch M, Dodge R, Look AT, Bowman P, George S, Pui C-H . Clinical pharmacodynamics of high-dose methotrexate in childhood acute lymphocytic leukemia. Identification of a relation between concentration and effect New Engl J Med 1986 314: 471\u2013477","journal-title":"New Engl J Med"},{"key":"BF2401673_CR25","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3109\/10428199609093433","volume":"21","author":"LH Matherly","year":"1996","unstructured":"Matherly LH, Taub JW . Methotrexate pharmacology and resistance in childhood acute lymphoblastic leukemia Leuk Lymphoma 1996 21: 359\u2013368","journal-title":"Leuk Lymphoma"},{"key":"BF2401673_CR26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1634\/theoncologist.1-4-223","volume":"1","author":"JR Bertino","year":"1996","unstructured":"Bertino JR, Goker E, Gorlick R, Li WW, Banerjee D . Resistance mechanisms to methotrexate in tumors Oncologist 1996 1: 223\u2013226","journal-title":"Oncologist"},{"key":"BF2401673_CR27","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1056\/NEJM199610033351408","volume":"335","author":"R Gorlick","year":"1996","unstructured":"Gorlick R, Goker E, Trippett T, Watham M, Banerjee D, Bertino JR . Intrinsic and acquired resistance to methotrexate in acute leukemia New Engl J Med 1996 335: 1041\u20131048","journal-title":"New Engl J Med"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2401673.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2401673","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2401673.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T20:28:21Z","timestamp":1648758501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2401673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1,25]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,2,1]]}},"alternative-id":["BF2401673"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2401673","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,1,25]]},"assertion":[{"value":"14 September 1999","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 1999","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2000","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}